Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133414) titled 'Metabolomic Profiling of Disease Course Dynamics and Precision Subtyping in Schizophrenia' on Sept. 26.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The Fourth People's Hospital of Chengdu
Condition:
Schizophrenia
Intervention:
First-episode drug-naive schizophrenia group:None
Clinically stable schizophrenia group:None
Chronic schizophrenia with predominant negative symptoms group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-08
Target Sample Size: First-episode drug-naive schizophrenia group:30;Clinically stable schizophreni...